ENTRY       mmu05211                    Pathway
NAME        Renal cell carcinoma - Mus musculus (mouse)
DESCRIPTION Renal cell cancer (RCC) accounts for ~3% of human malignancies and its incidence appears to be rising. Although most cases of RCC seem to occur sporadically, an inherited predisposition to renal cancer accounts for 1-4% of cases. RCC is not a single disease, it has several morphological subtypes. Conventional RCC (clear cell RCC) accounts for ~80% of cases, followed by papillary RCC (10-15%), chromophobe RCC (5%), and collecting duct RCC (<1%). Genes potentially involved in sporadic neoplasms of each particular type are VHL, MET, BHD, and FH respectively. In the absence of VHL, hypoxia-inducible factor alpha (HIF-alpha) accumulates, leading to production of several growth factors, including vascular endothelial growth factor and platelet-derived growth factor. Activated MET mediates a number of biological effects including motility, invasion of extracellular matrix, cellular transformation, prevention of apoptosis and metastasis formation. Loss of functional FH leads to accumulation of fumarate in the cell, triggering inhibition of HPH and preventing targeted pVHL-mediated degradation of HIF-alpha. BHD mutations cause the Birt-Hogg-Dube syndrome and its associated chromophobe, hybrid oncocytic, and conventional (clear cell) RCC.
CLASS       Human Diseases; Cancer: specific types
PATHWAY_MAP mmu05211  Renal cell carcinoma
ORGANISM    Mus musculus (mouse) [GN:mmu]
GENE        15251  Hif1a; hypoxia inducible factor 1, alpha subunit [KO:K08268]
            13819  Epas1; endothelial PAS domain protein 1 [KO:K09095]
            112407  Egln3; egl-9 family hypoxia-inducible factor 3 [KO:K09592] [EC:1.14.11.29]
            112406  Egln2; egl-9 family hypoxia-inducible factor 2 [KO:K09592] [EC:1.14.11.29]
            112405  Egln1; egl-9 family hypoxia-inducible factor 1 [KO:K09592] [EC:1.14.11.29]
            22346  Vhl; von Hippel-Lindau tumor suppressor [KO:K03871]
            67923  Eloc; elongin C [KO:K03872]
            67673  Elob; elongin B [KO:K03873]
            56438  Rbx1; ring-box 1 [KO:K03868] [EC:2.3.2.32]
            71745  Cul2; cullin 2 [KO:K03870]
            11863  Arnt; aryl hydrocarbon receptor nuclear translocator [KO:K09097]
            11864  Arnt2; aryl hydrocarbon receptor nuclear translocator 2 [KO:K15589]
            12914  Crebbp; CREB binding protein [KO:K04498] [EC:2.3.1.48]
            328572  Ep300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]
            20525  Slc2a1; solute carrier family 2 (facilitated glucose transporter), member 1 [KO:K07299]
            22339  Vegfa; vascular endothelial growth factor A [KO:K05448]
            21803  Tgfb1; transforming growth factor, beta 1 [KO:K13375]
            21808  Tgfb2; transforming growth factor, beta 2 [KO:K13376]
            21809  Tgfb3; transforming growth factor, beta 3 [KO:K13377]
            18591  Pdgfb; platelet derived growth factor, B polypeptide [KO:K17386]
            21802  Tgfa; transforming growth factor alpha [KO:K08774]
            15234  Hgf; hepatocyte growth factor [KO:K05460]
            17295  Met; met proto-oncogene [KO:K05099] [EC:2.7.10.1]
            14388  Gab1; growth factor receptor bound protein 2-associated protein 1 [KO:K09593]
            18706  Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            18707  Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            74769  Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            18709  Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            18708  Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            18710  Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            11651  Akt1; thymoma viral proto-oncogene 1 [KO:K04456] [EC:2.7.11.1]
            11652  Akt2; thymoma viral proto-oncogene 2 [KO:K04456] [EC:2.7.11.1]
            23797  Akt3; thymoma viral proto-oncogene 3 [KO:K04456] [EC:2.7.11.1]
            12015  Bad; BCL2-associated agonist of cell death [KO:K02158]
            12928  Crk; v-crk avian sarcoma virus CT10 oncogene homolog [KO:K04438]
            12929  Crkl; v-crk avian sarcoma virus CT10 oncogene homolog-like [KO:K04438]
            107746  Rapgef1; Rap guanine nucleotide exchange factor (GEF) 1 [KO:K06277]
            109905  Rap1a; RAS-related protein 1a [KO:K04353]
            215449  Rap1b; RAS related protein 1b [KO:K07836]
            19247  Ptpn11; protein tyrosine phosphatase, non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
            14784  Grb2; growth factor receptor bound protein 2 [KO:K04364]
            20662  Sos1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
            20663  Sos2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
            15461  Hras; Harvey rat sarcoma virus oncogene [KO:K02833]
            16653  Kras; Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
            18176  Nras; neuroblastoma ras oncogene [KO:K07828]
            11836  Araf; Araf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
            109880  Braf; Braf transforming gene [KO:K04365] [EC:2.7.11.1]
            110157  Raf1; v-raf-leukemia viral oncogene 1 [KO:K04366] [EC:2.7.11.1]
            26395  Map2k1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            26396  Map2k2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            26413  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            26417  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            23871  Ets1; E26 avian leukemia oncogene 1, 5' domain [KO:K02678]
            16476  Jun; jun proto-oncogene [KO:K04448]
            19353  Rac1; Rac family small GTPase 1 [KO:K04392]
            12540  Cdc42; cell division cycle 42 [KO:K04393]
            18479  Pak1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]
            224105  Pak2; p21 (RAC1) activated kinase 2 [KO:K04410] [EC:2.7.11.1]
            18481  Pak3; p21 (RAC1) activated kinase 3 [KO:K05733] [EC:2.7.11.1]
            70584  Pak4; p21 (RAC1) activated kinase 4 [KO:K05734] [EC:2.7.11.1]
            241656  Pak7; p21 (RAC1) activated kinase 7 [KO:K05736] [EC:2.7.11.1]
            214230  Pak6; p21 (RAC1) activated kinase 6 [KO:K05735] [EC:2.7.11.1]
            94315  Prcc; papillary renal cell carcinoma (translocation-associated) [KO:K13105]
            209446  Tfe3; transcription factor E3 [KO:K09105]
            12575  Cdkn1a; cyclin-dependent kinase inhibitor 1A (P21) [KO:K06625]
            14194  Fh1; fumarate hydratase 1 [KO:K01679] [EC:4.2.1.2]
            216805  Flcn; folliculin [KO:K09594]
COMPOUND    C00007  Oxygen
            C00122  Fumarate
            C00149  (S)-Malate
REFERENCE   PMID:16339096
  AUTHORS   Cohen HT, McGovern FJ.
  TITLE     Renal-cell carcinoma.
  JOURNAL   N Engl J Med 353:2477-90 (2005)
            DOI:10.1056/NEJMra043172
REFERENCE   PMID:15122209
  AUTHORS   Pavlovich CP, Schmidt LS.
  TITLE     Searching for the hereditary causes of renal-cell carcinoma.
  JOURNAL   Nat Rev Cancer 4:381-93 (2004)
            DOI:10.1038/nrc1364
REFERENCE   PMID:14634372
  AUTHORS   Linehan WM, Walther MM, Zbar B.
  TITLE     The genetic basis of cancer of the kidney.
  JOURNAL   J Urol 170:2163-72 (2003)
            DOI:10.1097/01.ju.0000096060.92397.ed
REFERENCE   PMID:15611513
  AUTHORS   Kim WY, Kaelin WG.
  TITLE     Role of VHL gene mutation in human cancer.
  JOURNAL   J Clin Oncol 22:4991-5004 (2004)
            DOI:10.1200/JCO.2004.05.061
REFERENCE   PMID:17211469
  AUTHORS   Sudarshan S, Linehan WM, Neckers L.
  TITLE     HIF and fumarate hydratase in renal cancer.
  JOURNAL   Br J Cancer 96:403-7 (2007)
            DOI:10.1038/sj.bjc.6603547
REFERENCE   PMID:17287871
  AUTHORS   Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  TITLE     Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  JOURNAL   Nat Clin Pract Urol 4:104-10 (2007)
            DOI:10.1038/ncpuro0711
REFERENCE   PMID:14685170
  AUTHORS   Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  TITLE     Met, metastasis, motility and more.
  JOURNAL   Nat Rev Mol Cell Biol 4:915-25 (2003)
            DOI:10.1038/nrm1261
REFERENCE   PMID:18358634
  AUTHORS   Muller-Hocker J, Babaryka G, Schmid I, Jung A
  TITLE     Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion.
  JOURNAL   Pathol Res Pract 204:589-97 (2008)
            DOI:10.1016/j.prp.2008.01.010
REFERENCE   PMID:12351585
  AUTHORS   Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  TITLE     Understanding familial and non-familial renal cell cancer.
  JOURNAL   Hum Mol Genet 11:2489-98 (2002)
            DOI:10.1093/hmg/11.20.2489
REFERENCE   PMID:25048860
  AUTHORS   Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM
  TITLE     Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.
  JOURNAL   Nat Rev Urol 11:465-75 (2014)
            DOI:10.1038/nrurol.2014.162
REFERENCE   PMID:11313942
  AUTHORS   Skalsky YM, Ajuh PM, Parker C, Lamond AI, Goodwin G, Cooper CS
  TITLE     PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.
  JOURNAL   Oncogene 20:178-87 (2001)
            DOI:10.1038/sj.onc.1204056
REFERENCE   PMID:19422821
  AUTHORS   Medendorp K, van Groningen JJ, Vreede L, Hetterschijt L, Brugmans L, van den Hurk WH, van Kessel AG
  TITLE     The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.
  JOURNAL   Exp Cell Res 315:2399-409 (2009)
            DOI:10.1016/j.yexcr.2009.04.022
REL_PATHWAY mmu00020  Citrate cycle (TCA cycle)
            mmu04010  MAPK signaling pathway
            mmu04066  HIF-1 signaling pathway
            mmu04120  Ubiquitin mediated proteolysis
            mmu04350  TGF-beta signaling pathway
            mmu04370  VEGF signaling pathway
KO_PATHWAY  ko05211
///
